Global Bio-chem Technology Group Company Limited
Global Bio-chem Technology Group Company Limited, an investment holding company, manufactures and sells corn refined products and corn-based biochemical products in the People's Republic of China, rest of Asia, the Americas, and internationally. It operates through four segments: Upstream Products, Amino Acids, Corn Sweeteners, and Polyol Chemicals. The company offers corn refined products, inclu… Read more
Global Bio-chem Technology Group Company Limited (GBCMY) - Net Assets
Latest net assets as of June 2025: $-2.21 Billion USD
Based on the latest financial reports, Global Bio-chem Technology Group Company Limited (GBCMY) has net assets worth $-2.21 Billion USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($4.69 Billion) and total liabilities ($6.89 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-2.21 Billion |
| % of Total Assets | -47.1% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | -8217.59% |
| Growth Volatility | 1844.73 |
Global Bio-chem Technology Group Company Limited - Net Assets Trend (2000–2024)
This chart illustrates how Global Bio-chem Technology Group Company Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Global Bio-chem Technology Group Company Limited (2000–2024)
The table below shows the annual net assets of Global Bio-chem Technology Group Company Limited from 2000 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-1.95 Billion | +51.59% |
| 2023-12-31 | $-4.04 Billion | +48.16% |
| 2022-12-31 | $-7.79 Billion | -16.21% |
| 2021-12-31 | $-6.70 Billion | -11.36% |
| 2020-12-31 | $-6.02 Billion | -38.45% |
| 2019-12-31 | $-4.35 Billion | -21.72% |
| 2018-12-31 | $-3.57 Billion | -44.76% |
| 2017-12-31 | $-2.47 Billion | -36.72% |
| 2016-12-31 | $-1.80 Billion | -7593.22% |
| 2015-12-31 | $24.08 Million | -98.09% |
| 2014-12-31 | $1.26 Billion | -75.31% |
| 2013-12-31 | $5.09 Billion | -54.66% |
| 2012-12-31 | $11.24 Billion | -5.26% |
| 2011-12-31 | $11.86 Billion | +22.64% |
| 2010-12-31 | $9.67 Billion | +20.33% |
| 2009-12-31 | $8.04 Billion | +1.75% |
| 2008-12-31 | $7.90 Billion | +14.73% |
| 2007-12-31 | $6.89 Billion | +36.42% |
| 2006-12-31 | $5.05 Billion | +6.52% |
| 2005-12-31 | $4.74 Billion | +2.48% |
| 2004-12-31 | $4.62 Billion | +64.35% |
| 2003-12-31 | $2.81 Billion | +36.92% |
| 2002-12-31 | $2.05 Billion | +44.29% |
| 2001-12-31 | $1.42 Billion | +287.98% |
| 2000-12-31 | $367.04 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Global Bio-chem Technology Group Company Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 875138400000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $890.74 Million | % |
| Other Comprehensive Income | $1.33 Billion | % |
| Other Components | $4.57 Billion | % |
| Total Equity | $-1.95 Billion | 100.00% |
Global Bio-chem Technology Group Company Limited Competitors by Market Cap
The table below lists competitors of Global Bio-chem Technology Group Company Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Jai Balaji Industries Limited
NSE:JAIBALAJI
|
$163.62 Million |
|
Chengdu Rainbow Appliance Gr
SHE:003023
|
$163.63 Million |
|
SKS Technologies Group Ltd
AU:SKS
|
$163.73 Million |
|
Global Atomic Corp
OTCQX:GLATF
|
$163.79 Million |
|
ST George Mining Ltd
AU:SGQ
|
$163.61 Million |
|
IBASE Technology
TWO:8050
|
$163.51 Million |
|
STRAITS TRADG SD 1
F:W2F
|
$163.49 Million |
|
Deceuninck
BR:DECB
|
$163.38 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Global Bio-chem Technology Group Company Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -4,036,906,000 to -1,954,390,000, a change of 2,082,516,000.
- Net income of 769,598,000 contributed positively to equity growth.
- Share repurchases of 2,583,000 reduced equity.
- New share issuances of 1,726,775,000 increased equity.
- Other comprehensive income decreased equity by 649,935,000.
- Other factors increased equity by 238,661,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $769.60 Million | +39.38% |
| Share Repurchases | $2.58 Million | -0.13% |
| Share Issuances | $1.73 Billion | +88.35% |
| Other Comprehensive Income | $-649.93 Million | -33.26% |
| Other Changes | $238.66 Million | +12.21% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Global Bio-chem Technology Group Company Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2000-12-31 | $16.48 | $0.49 | x |
| 2001-12-31 | $38.82 | $0.49 | x |
| 2002-12-31 | $40.00 | $0.49 | x |
| 2003-12-31 | $52.63 | $0.49 | x |
| 2004-12-31 | $84.34 | $0.49 | x |
| 2005-12-31 | $88.34 | $0.49 | x |
| 2006-12-31 | $93.65 | $0.49 | x |
| 2007-12-31 | $120.00 | $0.49 | x |
| 2008-12-31 | $137.16 | $0.49 | x |
| 2009-12-31 | $146.89 | $0.49 | x |
| 2010-12-31 | $158.24 | $0.49 | x |
| 2011-12-31 | $156.48 | $0.49 | x |
| 2012-12-31 | $148.19 | $0.49 | x |
| 2013-12-31 | $65.15 | $0.49 | x |
| 2014-12-31 | $12.60 | $0.49 | x |
| 2015-12-31 | $-1.87 | $0.49 | x |
| 2016-12-31 | $-14.10 | $0.49 | x |
| 2017-12-31 | $-18.81 | $0.49 | x |
| 2018-12-31 | $-26.94 | $0.49 | x |
| 2019-12-31 | $-30.56 | $0.49 | x |
| 2020-12-31 | $-34.45 | $0.49 | x |
| 2021-12-31 | $-36.59 | $0.49 | x |
| 2022-12-31 | $-42.32 | $0.49 | x |
| 2023-12-31 | $-22.66 | $0.49 | x |
| 2024-12-31 | $-10.94 | $0.49 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Global Bio-chem Technology Group Company Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 38.46%
- • Asset Turnover: 0.44x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-14.03%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2000 | 62.71% | 19.05% | 1.01x | 3.25x | $193.46 Million |
| 2001 | 23.18% | 23.82% | 0.68x | 1.42x | $187.67 Million |
| 2002 | 21.85% | 24.44% | 0.61x | 1.47x | $219.69 Million |
| 2003 | 20.86% | 22.35% | 0.55x | 1.69x | $271.11 Million |
| 2004 | 19.60% | 24.16% | 0.49x | 1.65x | $399.44 Million |
| 2005 | 9.84% | 11.44% | 0.43x | 1.98x | $-7.37 Million |
| 2006 | 9.93% | 10.57% | 0.45x | 2.09x | $-3.52 Million |
| 2007 | 15.16% | 14.42% | 0.51x | 2.07x | $333.51 Million |
| 2008 | 8.42% | 7.06% | 0.57x | 2.09x | $-117.00 Million |
| 2009 | -0.20% | -0.19% | 0.46x | 2.27x | $-763.17 Million |
| 2010 | 3.81% | 3.56% | 0.47x | 2.28x | $-538.09 Million |
| 2011 | 12.86% | 9.07% | 0.61x | 2.33x | $291.49 Million |
| 2012 | -5.73% | -4.66% | 0.52x | 2.37x | $-1.52 Billion |
| 2013 | -143.00% | -62.78% | 0.52x | 4.42x | $-6.51 Billion |
| 2014 | -409.99% | -52.68% | 0.47x | 16.73x | $-3.45 Billion |
| 2015 | 0.00% | -59.55% | 0.27x | 0.00x | $-1.98 Billion |
| 2016 | 0.00% | -47.66% | 0.39x | 0.00x | $-1.67 Billion |
| 2017 | 0.00% | -19.05% | 0.41x | 0.00x | $-596.74 Million |
| 2018 | 0.00% | -21.60% | 0.58x | 0.00x | $-877.53 Million |
| 2019 | 0.00% | -23.60% | 0.55x | 0.00x | $-656.83 Million |
| 2020 | 0.00% | -286.65% | 0.11x | 0.00x | $-1.85 Billion |
| 2021 | 0.00% | -53.69% | 0.12x | 0.00x | $250.97 Million |
| 2022 | 0.00% | -11352.91% | 0.00x | 0.00x | $-689.17 Million |
| 2023 | 0.00% | 307.48% | 0.26x | 0.00x | $4.63 Billion |
| 2024 | 0.00% | 38.46% | 0.44x | 0.00x | $965.04 Million |
Industry Comparison
This section compares Global Bio-chem Technology Group Company Limited's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $5,681,533,529
- Average return on equity (ROE) among peers: 0.04%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Global Bio-chem Technology Group Company Limited (GBCMY) | $-2.21 Billion | 62.71% | N/A | $163.62 Million |
| Above Food Ingredients Inc. Common Stock (ABVE) | $30.90K | -3.31% | 7.66x | $18.76 Million |
| The a2 Milk Company Limited (ACOPF) | $7.27 Million | -30.19% | 0.14x | $3.91 Billion |
| Ayujoy Herbals Ltd (AJOY) | $22.20 Million | 29.29% | 0.00x | $95.71 |
| Alfa S.A.B. de C.V (ALFFF) | $53.35 Billion | 7.36% | 3.80x | $2.16 Billion |
| Amincor Inc (AMNCB) | $34.44 Million | -63.76% | 0.81x | $2.24K |
| Armanino Foods New (AMNF) | $21.40 Million | 30.30% | 0.33x | $72.33K |
| Amira Nature Foods Ltd (ANFIF) | $303.22 Million | 8.27% | 0.89x | $128.79 |
| AAK AB (publ.) (ARHUF) | $2.44 Billion | 12.85% | 2.63x | $5.07 Billion |
| Artisan Consumer Goods Inc (ARRT) | $-326.75K | 0.00% | 0.00x | $279.39K |
| ARYZTA AG (ARZTF) | $632.10 Million | 9.58% | 2.04x | $53.13 Million |